Valuation: iCAD Inc

Market Cap 11Cr 9.27Cr 8.62Cr 7.91Cr 15Cr 1.02TCr 15Cr 102.42Cr 40Cr 499.93Cr 40Cr 39Cr 1.73TCr P/E 2023
-9.35x
P/E 2024 -8.59x
Enterprise Value 8.87Cr 7.79Cr 7.25Cr 6.65Cr 12Cr 854.66Cr 13Cr 86Cr 34Cr 420.18Cr 33Cr 33Cr 1.45TCr EV / Sales 2023
1.47x
EV / Sales 2024 1.6x
Free-Float
99.32%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 61 10/03/2023
Director of Finance/CFO 54 17/07/2025
Corporate Secretary - 17/07/2025
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%+6.72%+19.63%-0.57% 21TCr
-0.52%-6.05%-5.58%-25.77% 13TCr
+1.65%-2.29%-30.93%+4.31% 12TCr
+1.54%+0.50%-58.34%-15.18% 6.58TCr
-1.42%-3.62%+9.01%-9.60% 4.76TCr
+3.03%-0.17%-26.81%-31.58% 4.44TCr
-0.84%+5.41%+15.14%+8.50% 3.91TCr
-2.02%+1.54%+25.53%+30.56% 3.68TCr
-1.41%+3.99%+80.31%+3.20% 2.94TCr
Average -0.08%+0.47%+3.11%-4.01% 8.09TCr
Weighted average by Cap. -0.00%+0.37%-1.38%-6.02%

Financials

2023 2024
Net sales 1.73Cr 1.52Cr 1.41Cr 1.3Cr 2.44Cr 166.77Cr 2.48Cr 17Cr 6.56Cr 82Cr 6.5Cr 6.36Cr 283.49Cr 1.96Cr 1.72Cr 1.6Cr 1.47Cr 2.76Cr 188.83Cr 2.8Cr 19Cr 7.43Cr 93Cr 7.36Cr 7.2Cr 320.98Cr
Net income -48.47L -42.57L -39.59L -36.33L -68.26L -47Cr -69.31L -4.7Cr -1.84Cr -23Cr -1.82Cr -1.78Cr -79Cr -56.16L -49.33L -45.87L -42.09L -79.09L -54Cr -80.31L -5.45Cr -2.13Cr -27Cr -2.11Cr -2.06Cr -92Cr
Net Debt -2.12Cr -1.86Cr -1.73Cr -1.59Cr -2.99Cr -204.25Cr -3.03Cr -21Cr -8.04Cr -100.41Cr -7.96Cr -7.79Cr -347.18Cr -1.68Cr -1.48Cr -1.38Cr -1.26Cr -2.37Cr -162.21Cr -2.41Cr -16Cr -6.38Cr -80Cr -6.32Cr -6.19Cr -275.73Cr
Logo iCAD Inc
iCAD Inc is a United States‑based company. The Company develops artificial intelligence solutions designed to support healthcare providers in the detection and diagnosis of cancer. The company focuses on providing clinically proven AI technologies that assist medical professionals in identifying cancer earlier, improving diagnostic accuracy, and enhancing workflow efficiency. Its solutions include platforms for cancer detection, breast density assessment, and risk evaluation, enabling clinicians to analyze medical images and support patient care decisions. The company leverages advanced data, clinical evidence, and AI‑driven technologies to deliver tools that integrate into existing healthcare systems and assist in screening and diagnostic processes across global markets.
Employees
-